Why the study?
Does percutaneous coronary intervention reduce 30-day and 1-year mortality in patients presenting with STEMI between 12 hours and 28 days compared to conservative therapy?
Cohort (n=5,523)
No
Does percutaneous coronary intervention reduce 30-day and 1-year mortality in patients presenting with STEMI between 12 hours and 28 days compared to conservative therapy?
Answers are grounded in this paper and cite their sources.
In a real-world cohort of late-presenting STEMI patients (12 hours to 28 days), PCI was associated with significantly lower 30-day and 1-year mortality compared to conservative therapy across all age groups.
OBJECTIVES: Percutaneous coronary intervention( PCI) for ST-elevation myocardial infarction (STEMI) has been widely accepted for patient who come within 12 hours, but for those who come to the hospital late (12 hours to 28 days) the long-term data and possible predictors are limited regarding 'hard' endpoints in 'real world'. METHODS: The registry data of all 5523 consecutive patients admitted due to an incident STEMI (12 hours to 28 days) in our center were analyzed. Patients were divided into 3 age groups (age<65; age = 65-74; age ≥75) and two therapeutic groups including conservative and PCI group. The primary endpoints included 30-day mortality and 1-year mortality. RESULTS: The clinical characteristics include female gender; history of diabetes mellitus, previous myocardial infarction, cerebral vascular disease, chronic renal failure, atrial fibrillation, hypertension, anemia, gastric bleeding; presentation of ventricular tachycardia/ventricular fibrillation, pneumonia, heart failure, multiple organ failure and cardiogenic shock. The ratio of all the above factors increased with the age getting older (all p<0.05), while that of the PCI decreased significantly with ageing (53.9%, 36.3% and 21.7%). Except hypertension, all the other factors were less seen in the PCI group than in the conservative group (p<0.01). Pooled estimates, based on type of therapy and age groups, PCI resulted in significantly lower 30-day and 1-year mortality. Cox analysis showed the positive predictors for 30 days and 1 year mortality were heart failure, cerebral vascular disease, chronic renal failure, ventricular tachycardia/ventricular fibrillation, age, female, gastric intestinal bleeding, cardiogenic shock, multiple organ failure, while PCI was a negative predictor. ROCs analysis showed AUCs were always higher for PCI group. CONCLUSIONS: The elderly have more comorbidities and higher rates of mortality, mandating thorough evaluation before acceptance for PCI. PCI between 12 hours to 28 days in all ages of patients including the elderly with STEMI is significantly more effective than conservative therapy.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2013) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=5,523). Percutaneous coronary intervention vs. Conservative therapy was evaluated on 30-day mortality and 1-year mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: